Difficulty: Medium
Average Score: 77%
Practice
Which of the following features do MAO inhibitors and tricyclic antidepressants have in common?
Correct answer
C
Rationale
The correct answer is C) Increase levels of biogenic amines.
MAO inhibitors and tricyclic antidepressants both work by inhibiting the reuptake of neurotransmitters such as serotonin, norepinephrine, and dopamine. By blocking the action of monoamine oxidase (MAO) or inhibiting the reuptake of these neurotransmitters, both types of medications lead to an increase in the levels of biogenic amines in the synaptic cleft, ultimately enhancing neurotransmission and improving mood in individuals with depression.
Option A) Act postsynaptically to produce their effect is incorrect because MAO inhibitors and tricyclic antidepressants primarily act presynaptically by altering neurotransmitter levels in the synaptic cleft.
Option B) Can precipitate hypotensive crises if certain foods are ingested is incorrect because this statement is more specific to MAO inhibitors due to the potential interaction with foods rich in tyramine, leading to hypertensive crises, not hypotensive crises.
Option D) Are useful for the manic phase of bipolar disorder is incorrect because while tricyclic antidepressants can sometimes be used in bipolar disorder, they are not considered first-line treatments for the manic phase. Antidepressants can potentially induce manic episodes in individuals with bipolar disorder, so they are generally used cautiously and in combination with mood stabilizers.
Understanding the similarities and differences between MAO inhibitors and tricyclic antidepressants is crucial for healthcare professionals, especially when prescribing these medications to patients. It is essential to understand their mechanisms of action, potential side effects, drug interactions, and appropriate clinical uses to ensure safe and effective pharmacological treatment for individuals across the lifespan.
MAO inhibitors and tricyclic antidepressants both work by inhibiting the reuptake of neurotransmitters such as serotonin, norepinephrine, and dopamine. By blocking the action of monoamine oxidase (MAO) or inhibiting the reuptake of these neurotransmitters, both types of medications lead to an increase in the levels of biogenic amines in the synaptic cleft, ultimately enhancing neurotransmission and improving mood in individuals with depression.
Option A) Act postsynaptically to produce their effect is incorrect because MAO inhibitors and tricyclic antidepressants primarily act presynaptically by altering neurotransmitter levels in the synaptic cleft.
Option B) Can precipitate hypotensive crises if certain foods are ingested is incorrect because this statement is more specific to MAO inhibitors due to the potential interaction with foods rich in tyramine, leading to hypertensive crises, not hypotensive crises.
Option D) Are useful for the manic phase of bipolar disorder is incorrect because while tricyclic antidepressants can sometimes be used in bipolar disorder, they are not considered first-line treatments for the manic phase. Antidepressants can potentially induce manic episodes in individuals with bipolar disorder, so they are generally used cautiously and in combination with mood stabilizers.
Understanding the similarities and differences between MAO inhibitors and tricyclic antidepressants is crucial for healthcare professionals, especially when prescribing these medications to patients. It is essential to understand their mechanisms of action, potential side effects, drug interactions, and appropriate clinical uses to ensure safe and effective pharmacological treatment for individuals across the lifespan.